Table 1.
Characteristics of myeloma patients included in this study
| Pat. code | Paraprotein isotype | Allo-Tx date | APB after allo-Tx | Serum sample collection dates | Response at day 100/12 months after allo-Txa |
|---|---|---|---|---|---|
| MM023 | IgG kappa | 04/09 | + | 03/09 (pre-Tx), 06/09, 08/09, 11/09, 08/10 | CR/CR |
| MM025 | IgG kappa | 11/09 | + | 03/09 (pre-Tx), 03/10, 09/10, 05/11 | PR/CR |
| MM031 | IgG lambda | 05/10 | + | 03/10 (pre-Tx), 09/10, 02/11, 05/11 | CR/CR |
| MM040 | IgG kappa | 10/09 | + | 03/11 | CR/CR |
| MM041 | Lambda LC | 12/09 | + | 03/11 | PR/CR |
| MM043 | IgG kappa | 09/10 | + | 03/11 | CR/CR |
| MM045 | IgG lambda | 02/10 | + | 03/11 | CR/CR |
| MM046 | IgA lambda | 10/09 | + | 03/11 | CR/CR |
| MM047 | IgG lambda | 11/09 | + | 03/11 | vgPR/vgPR |
| MM051 | IgG kappa | 09/10 | + | 04/11 | PR/PD |
| MM054 | IgG kappa | 02/11 | + | 06/11 | CR/n.e. |
| MM033 | IgA kappa | 01/11 | − | 05/11 | PR/PR |
| MM037 | IgG lambda | 11/10 | − | 03/11 | PD/PD |
| MM038 | IgG kappa | 12/09 | − | 03/11 | vgPR/vgPR |
| MM039 | IgG lambda | 04/10 | − | 03/11 | SD/SD |
Pat. patient, MM multiple myeloma, APB abnormal protein bands, allo-Tx allogeneic stem cell transplantation, pre-Tx serum samples that had been collected prior to transplantation, LC light chain, CR complete remission, vgPR very good partial remission, PR partial remission, SD stable disease, PD progressive disease
aResponse to treatment was assessed using the IMWG uniform response criteria